Vet-Stem Regenerative Stem Cell Therapy
Since its formation in 2002, Vet-Stem, Inc. has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem pioneered the use of regenerative stem cells in veterinary medicine; Vet-Stem holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells.
In January of 2004 the first horse was treated with Vet-Stem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. By August 2007, 2,000 horses had been treated with their own healing stem cells with a high return to performance activity. By December of 2010, the number of horses treated reached 4,000.
Building on the success in equine cases, in 2005 Vet-Stem began working with select veterinary clinics in treating dogs with osteoarthritis and orthopedic soft tissue injuries. In 2007, Vet-Stem had the first published peer reviewed blinded placebo controlled multi-center study showing a significant difference for stem cell treated dogs in OA of the hip. In May 2007 the company began offering stem cell services for the commercial treatment of dogs and cats, and by January of 2011 over 3,000 had undergone the therapy.
If it is determined that a pet may benefit from stem cell therapy, a surgical procedure is scheduled for the pet to undergo the first stage of the procedure. Adipose tissue, commonly referred to as fat tissue, is harvested from a small incision in the abdominal region.
The tissue is then placed in is specially provided sterile containers containing special media, placed on ice, then immediately rushed to Vet-Stem via FedEx along with with specific information regarding the site of the planned treatment area.
Vet-Stem then processes the tissue using sterile Bio-Safety cabinets inside hep-filtered clean rooms by technician with years of experience with thousands of samples. Prior to shipping back the samples within 48 hours of harvesting, Vet-Stem determines the cell yield and viability of each sample.
Once the stem-cells are returned to us, they are reintroduced back into the patient’s most affected areas within an hour of arrival in a second procedure requiring only minor sedation. Once the patient is fully recovered from sedation, they are sent home the very same day.
Are All Stem Cell Companies Alike?
There are among 3 major areas where Vet-Stem sets itself apart from other stem cell companies claiming the same amazing benefits that Vet-Stem has been providing for nearly 10 years:
- Vet-Stem technicians have years of experience with thousands of samples
- Vet-Stem uses sterile Bio-Safety cabinets inside hepa-filtered clean rooms
- Vet-Stem determines the cell yield and viability of each sample prior to shipment
- Vet-Stem counts cells using industry established methods in order to ensure accurate dosing
- Vet-Stem has tested stability of tissue and cells during transit up to 48 hours
- Vet-Stem has peer reviewed published studies and clinical outcome data from hundreds of owners and veterinarians
- Vet-Stem has clinical outcome data from hundreds of owners and veterinarians
- Vet-Stem has provided Stem Cell services for over 6,500 animals. Several veterinarians have treated over 200 animals
- Patient and Owner Benefit
- Vet-Stem can provide therapy from as little as 5 grams and as much as 200 grams of adipose tissue
- Vet-Stem stores extra doses from the initial process at no charge for one year. Thereafter, there is a minimal fee of $50 a year to bank the cells for future use
- Only one adipose collection is needed for a lifetime of treatments
- A full time dedicated Customer Service staff supports owners and clinic staff
In the end, the decision of which company individuals wish to intrust their pet’s precious stem cells and their hard-earned finances to is in the hands of the patient’s owner. Who will you trust your pet to? Copycat companies promising the same benefits without the same level of quality control or the pioneers of regenerative stem cell therapy in pets?